Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Immune-Mediated Necrotizing Myopathy following mRNA SARS-CoV-2 Vaccination
The new coronavirus (COVID-19) pandemic has resulted in the unprecedented production of vaccines. In this context, the possible adverse effects remain to be identified and reported. In this article, we report the case of a young female patient who developed anti-3-hydroxy-3-methylglutaryl-coenzyme A...
Saved in:
Main Authors: | Marta Rodrigues de Carvalho, Myrian Mathildes Sá de Deus Rocha, Vinícius Alves Bezerra, Maciel Eduardo de Pontes, Maria Cristina del Negro, Julio Salgado Antunes, Vinícius Viana Abreu Montanaro, Rubens Nelson Morato Fernandez |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-01-01
|
Series: | Case Reports in Neurological Medicine |
Online Access: | http://dx.doi.org/10.1155/2023/7061783 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hypercholesterolemia and 3-Hydroxy 3-Methylglutaryl Coenzyme A Reductase Regulation during Ageing
by: Laura Trapani, et al.
Published: (2009-01-01) -
Analysis of Autoantibodies to 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Using Different Technologies
by: Lucile Musset, et al.
Published: (2014-01-01) -
The protective effect of coadministration of coenzyme Q10 and vitamin E on myopathy induced by simvastatin in rats
by: Omar Ammar Hashim, et al.
Published: (2025-06-01) -
Genetic and biochemical characterization of a radical SAM enzyme required for post-translational glutamine methylation of methyl-coenzyme M reductase
by: Roy J. Rodriguez Carrero, et al.
Published: (2025-02-01) -
Challenges in Treating Statin-Associated Necrotizing Myopathy
by: Patrick Webster, et al.
Published: (2021-01-01)